The drivers of health care costs, federal spending, consumer spending, and industry consolidation.
During this briefing, panelists discussed factors policymakers must consider in order to support access to safe, effective, and affordable cell and gene therapies.
During this on-the-record briefing for reporters, Joe Grogan, Assistant to the President and Director of the Domestic Policy Council provided opening remarks and responded to questions from reporters. The question and answer period was moderated by William Pierce, Senior Director, APCO Worldwide.
During this congressional lunch briefing, analysts will outline the mechanisms of the Medicare Part D program under current law and discuss the potential implications of reforms put forward by Congress and the administration.
During this briefing, panelists will discuss components of policy proposals under consideration and explore evidence about their implications for the health care system.
This briefing will explore the economic, budgetary, and infrastructure issues that arise when creating outcome-oriented investments for social determinants of health.
During this webinar, analysts discussed the outstanding legislative and regulatory activities that Congress and the administration are likely to pursue before the end of the year.
This webinar outlined the various PCORI reauthorization bills and amendments that have been discussed by House and Senate committees to date. Our panel of experts explored some of the critical questions facing congressional staff and discussed potential next steps in the legislative process.
During this briefing, expert panelists discussed considerations for policy options to protect consumers from surprise medical bills.
There is no excerpt because this is a protected post.
This summit brought together multi-stakeholder perspectives to examine current policies and practices on social determinants of health and accelerate solutions to improve health outcomes in the U.S.
During this briefing, panelists explained the mechanisms of biologic drugs, explore the impact of current regulations on the uptake of biosimilars, and discuss considerations for the biosimilars market in the United States.
The audience will come away with a better understanding of the origins of the rebate system, the actors responsible for negotiation, and the impact of rebates on prescription drug prices.
This congressional briefing explored the differences between “price” and “cost” in our current system and the potential policy options that address these discrepancies.
The conversation on health care costs in America is decades old, yet progress has been elusive. Terms like sustainability, affordability, and value are set forward as goals, but perspectives on how to achieve them vary widely. Speakers and panelists will provide insights on current and projected health care cost trends, what different stakeholders hope to achieve, and new approaches to consider.
This is the first webinar, part of the Beyond the Beltway: Health Webinars for Journalists series, focused on the implications and tradeoffs of the recent trends in the health care market. Panelists helped define the basics of market concentration and competition, how experts measure the effects on different areas of the market, and how regulators approach assessing partnership proposals.
This briefing provided an update on the overall state of play with payment reform, and the effort to move away from fee for service and toward value-based payment. Panelists discussed the interplay between the public and private sectors, and, given likely future directions for the CMS Center for Medicare and Medicaid Innovation, highlighted areas where the private sector may be best positioned to lead. Panelists shared what this means for future policy options and needs.
This Alliance for Health Policy briefing discussed current issues in prescription drug affordability and innovation, focusing on potential policy and private-sector approaches to this complex issue.
Coordinated Care and Beyond: The Future of Integrated Care for Complex Chronic Conditions: What’s Working, What’s Not?
This is the final of three panels from our Future of Chronic Care Summit.
This is the second of three panels from our Future of Chronic Care Summit.
This is the first of three panels from our Future of Chronic Care Summit.
This half-day summit examined how to improve care for patients with complex, chronic conditions.
This briefing featured presentations by our experts highlighting the trends in Medicare regarding prescription drug pricing, and panelists discussed an array of policy options to align drug prices with value through alternative payment models.
Medicaid is testing numerous new alternative payment and delivery system models to enhance the coordination of the health care services provided to millions of low-income Americans. This briefing examined the range of Medicaid’s efforts to improve care and promote value, including integrating health with non-clinical and behavioral services, creating managed care organizations, and instituting regional care collaborative organizations. Our panel also addressed Medicaid’s role in managing emerging issues such as the opioid epidemic and the spread of the Zika virus.
Health systems have applied many innovative new strategies for improving quality and reducing costs when it comes to care for high-need, high-cost patients, who typically have multiple chronic conditions. Which of these innovations show promise, and what can we learn from them?